Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP414517.RAq3ElgpVHjnaX0h-o8B2ly2sf9KF_N_tH0AWtc7Y_ZHo130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP414517.RAq3ElgpVHjnaX0h-o8B2ly2sf9KF_N_tH0AWtc7Y_ZHo130_assertion type Assertion NP414517.RAq3ElgpVHjnaX0h-o8B2ly2sf9KF_N_tH0AWtc7Y_ZHo130_head.
- NP414517.RAq3ElgpVHjnaX0h-o8B2ly2sf9KF_N_tH0AWtc7Y_ZHo130_assertion description "[However, genetic ablation of MyD88 or TRIF/type-I interferon signaling pathways prevented hyper-inflammation and attenuated the pathogenic consequences of sepsis indicating that dampening common signaling pathways may create a moderate signal strength which is associated with favorable immune responses.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP414517.RAq3ElgpVHjnaX0h-o8B2ly2sf9KF_N_tH0AWtc7Y_ZHo130_provenance.
- NP414517.RAq3ElgpVHjnaX0h-o8B2ly2sf9KF_N_tH0AWtc7Y_ZHo130_assertion evidence source_evidence_literature NP414517.RAq3ElgpVHjnaX0h-o8B2ly2sf9KF_N_tH0AWtc7Y_ZHo130_provenance.
- NP414517.RAq3ElgpVHjnaX0h-o8B2ly2sf9KF_N_tH0AWtc7Y_ZHo130_assertion SIO_000772 18086373 NP414517.RAq3ElgpVHjnaX0h-o8B2ly2sf9KF_N_tH0AWtc7Y_ZHo130_provenance.
- NP414517.RAq3ElgpVHjnaX0h-o8B2ly2sf9KF_N_tH0AWtc7Y_ZHo130_assertion wasDerivedFrom befree-20140225 NP414517.RAq3ElgpVHjnaX0h-o8B2ly2sf9KF_N_tH0AWtc7Y_ZHo130_provenance.
- NP414517.RAq3ElgpVHjnaX0h-o8B2ly2sf9KF_N_tH0AWtc7Y_ZHo130_assertion wasGeneratedBy ECO_0000203 NP414517.RAq3ElgpVHjnaX0h-o8B2ly2sf9KF_N_tH0AWtc7Y_ZHo130_provenance.